Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Cancer Immunity, an open access journal of the Cancer Research Institute

Editor's View

  • Editor's View
    An open invitation to the cancer immunology community
    Pramod K. Srivastava, Vincenzo Cerundolo, Alexander Knuth and James P. Allison
    Cancer Immun January 1 2012 12 (1)

Reflections

  • Reflections
    Cell surface antigens: invaluable landmarks reflecting the nature of cells
    Toshitada Takahashi and Hiroshi Shiku
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    Autologous typing: a tedious but orthodox approach for defining human tumor antigens with clarity
    Hiroshi Shiku and Toshitada Takahashi
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    A man of vision and the discovery of tumor necrosis factor
    Elizabeth A. Carswell-Richards and Barbara D. Williamson
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    Identification of chaperones as essential components of the tumor rejection moieties of cancers
    Pramod K. Srivastava
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    The discovery of Cancer/Testis antigens by autologous typing with T cell clones and the evolution of cancer vaccines
    Elke Jäger and Alexander Knuth
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    The genealogy of SEREX
    Michael Pfreundschuh
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    The journey from autologous typing to SEREX, NY-ESO-1, and Cancer/Testis antigens
    Yao-Tseng Chen
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    “But Dr. Old, we already have an antibody!” Reflections on Lloyd Old’s “academic biotech” approach for targeted antibodies
    Gerd Ritter
    Cancer Immun January 1 2012 12 (1)

  • Reflections
    The Cancer Vaccine Collaborative: a new model of coordinated discovery
    Jill O’Donnell-Tormey and Edward A. McDermott Jr.
    Cancer Immun January 1 2012 12 (1)

Commentaries

  • Commentaries
    Introduction to monoclonal antibodies
    Jean-Pierre Mach
    Cancer Immun January 1 2012 12 (1)

  • Commentaries
    Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on
    Gert Riethmüller
    Cancer Immun January 1 2012 12 (1)

  • Commentaries
    Translating basic mechanisms of IgG effector activity into next generation cancer therapies
    Falk Nimmerjahn and Jeffrey V. Ravetch
    Cancer Immun January 1 2012 12 (1)

  • Commentaries
    Monoclonal antibodies in cancer therapy
    Andrew M. Scott, James P. Allison and Jedd D. Wolchok
    Cancer Immun January 1 2012 12 (1)

Back to top
PreviousNext
Cancer Immunity Archive: 12 (1)
January 2012
Volume 12, Issue 1
  • Table of Contents

Sign up for alerts

Jump to

  • Editor's View
  • Reflections
  • Commentaries
Advertisement
  • Most Cited
  • Most Read
Loading
  • Activity of Anti-CTLA-4 Isotypes in Antitumor Responses
  • Masters of Immunology
  • Characterization of Murine Syngeneic Tumor Models
  • Extending Reach of Checkpoint Blockade in Pancreatic Cancer
  • Case Report: RNA CAR T Cells
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement